Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Alan Lambowitz
University of Texas, Austin, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
InGex, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The Covered Individual and a Covered Family Member hold equity interest in InGex, LLC. The Covered Individual conducts research on intellectual property involving targetron technology and group II intron reverse transcriptases that is licensed by the University to InGex, LLC for commercialization.
Mobile Group II Introns and Their Reverse Transcriptases
Public Health Relevance: The proposed research on mobile group II introns and group II intron-encoded and related reverse transcriptase will provide novel information about the mechanism and evolution of RNA splicing, introns, innate immunity, retrotransposons, and retroviruses, all of which are relevant to human diseases. The proposed research also includes the development of new methods for next-generation RNA sequencing, and the application of these methods to investigate the origin and function of human exosomal and plasma RNAs, potentially leading to new RNA-based diagnostics for human diseases. �
Filed on July 25, 2019.
Tell us what you know about Alan Lambowitz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Alan Lambowitz”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Alan Lambowitz | University of Texas, Austin | Financial Disclosure | RNA Institute of University of Albany, State University of New York | |
| Alan Lambowitz | University of Texas, Austin | Financial Disclosure | InGex, LLC | |
| Alan Lambowitz | University of Texas, Austin | Financial Disclosure | InGex, LLC | |
| Alan Lambowitz | University of Texas, Austin | Financial Disclosure | RNA Institute of University of Albany, State University of New York |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.